[Translation] A randomized, open-label, single-dose, two-dose bioequivalence formal trial of cefaclor granules in Chinese healthy subjects
以万邦德制药集团有限公司的头孢克洛颗粒为受试制剂;并以苏州西克罗制药有限公司持证的头孢克洛干混悬剂(商品名:希刻劳®)为参比制剂,进行人体相对生物利用度和生物等效性评价。
[Translation] Cefaclor granules from Wanbangde Pharmaceutical Group Co., Ltd. were used as the test preparation; and cefaclor dry suspension licensed by Suzhou Sikero Pharmaceutical Co., Ltd. (trade name: Cefaclor®) was used as the reference preparation. Carry out human relative bioavailability and bioequivalence evaluation.